Stability and Cytotoxicity of a Cosmetic Cream Containing Oil from Lecythis pisonis Cambess (Sapucaia) Nuts.

Lecythis pisonis nuts are rich in tocopherols, polyphenols, and fatty acids, and hence, the quality of oil was analyzed for use in the elaboration of skin cream. Nut oil was extracted with hexane in a Soxhlet apparatus. The quality and safety of the oil were tested by using established protocols from Adolf Lutz Institute. Three concentrations, 1%, 5%, and 10%, of oil were incorporated into a formulated cream. The oil formulations were evaluated for their stability, organoleptic characteristics, pH, viscosity, spreadability, challenge test, cellular viability, and their response to microbial contamination, as recommended by the National Health Surveillance Agency (ANVISA). Quality analysis demonstrated the high quality of the obtained oil, with no traces of heavy metals and no toxic effects on ingestion. The cream containing L. pisonis nut oil is stable, has an effective preservative system, and is considered safe for use because it presented no toxicity in human cells. A stabilizer is required to maintain the pH in the range suitable for a body cream. Of the formulations tested, the cream containing 5% nut oil was the most stable and had presented the best organoleptic characteristics.

Development and evaluation of a vegetable oil blend formulation for cutaneous wound healing.

This work aimed to evaluate the in vivo capacity of a vegetable oil blend formulation (VOB) developed to accelerate cutaneous wound closure. Total thickness wounds were punctured on the skin on the back side of each animal and topically treated with the VOB formulation, Dersani® ointment or the vehicle control. After 2, 7, 14, 21 days post-wounding, five animals from each group were euthanized, and the rates of wound closure and re-epithelialization were evaluated. The wounds were harvested for histological and biochemical analysis. VOB resulted in faster and greater re-epithelialization in the in vivo excisional wounds, exhibiting significant wound area reduction of 8.9, 8.0, 35.1, 45.2 and 47.0% after 2, 5, 10, 14 and 21 days post-wounding, respectively, when compared with the vehicle control. Histological and biochemical analyses showed that the VOB-treated wounds exhibited a significant increase of granular tissue and controlled inflammatory response by modulation of the release of pro-inflammatory cytokines TNF-α, IL-6 and IL-1. Moreover, VOB-treated wounds showed a significant and concrete increase in the deposition and organisation of collagen fibres in the wound site and improved the quality of the scar tissue. Altogether, these data revealed that VOB accelerates wound healing processes and might be beneficial for treating wound disorders.